Browsing by Keyword : Neoplasm, Residual
Showing results 5 to 15 of 15
Pub Year | | Title | Author(s) |
2012 | | Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining 'optimal' residual disease | 장석준 |
1999 | | Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer. | 고중화, 박찬희, 서정호 |
2016 | | Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study | 박준성 |
2001 | | Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization. | 김영배 |
2012 | | Pathologic diagnosis of recurrent glioblastoma: morphologic, immunohistochemical, and molecular analysis of 20 paired cases | 김보영, 김세혁, 김영배, 김장희, 신승수, 이기범, 이현우, 정선용, 한재호 |
2012 | | Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer | 유희석, 장석준 |
2013 | | Radiofrequency ablation of metastatic liver masses: recurrence patterns and prognostic factors based on radiologic features. | 김재근, 김태희, 박미진, 이기명, 정재연 |
2015 | | Role of aggressive surgical cytoreduction in advanced ovarian cancer. | 장석준 |
2019 | | Selection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy: A systematic review and meta-analysis | 장석준 |
2015 | | Surgical technique of en bloc pelvic resection for advanced ovarian cancer. | 장석준 |
2013 | | Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis. | 장석준 |
1